WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

China Releases Updated NRDL and First Commercial Insurance Innovative Drug Lis... China announced on December 7 the release of an updated National Reimbursement Drug List (NRDL) and the country's first Commercial Insurance Innovative Drug List, marking...
(12/8/2025)

NSCEB: US Faces Urgent Challenge to Stay Ahead... (12/23/2025)

China Biopharma Licensing Slows in Value as Ov... (12/22/2025)

U.S. Biosecurity Provisions Could Reshape Chin... (12/19/2025)

Understanding China's Pharmaceutical Patent Li... (12/17/2025)

Understanding China's Pharmaceuticals Patent L... (12/17/2025)

China's New Drug Commercial Insurance Scheme O... (12/17/2025)

Innovative Drugs: The New Battleground in US-C... (12/11/2025)

Chinese Biopharma Sector Posts 22 Financings ... (12/11/2025)

China Tightens Oversight as Domestic Innovator... (12/11/2025)

Global Pharmas Turn to China Not Just for Asse... (12/9/2025)

China Launches National Drug Price Registratio... (12/2/2025)

NHC Releases 2024 China Health Statistics Bull... (12/2/2025)

Aurobindo Pharma to Increase Stake in Ch... (12/23/2025) CSPC Announces China Approval for Daratu... (12/23/2025) Grand Secures China Rights to World's F... (12/23/2025) Qilu Launches Phase 1 Trial of FIC CD3/C... (12/23/2025) Ipsen Expands Oncology Pipeline with Glo... (12/23/2025) T-MAXIMUM Secures FDA Approval to Advanc... (12/23/2025) PepBio Raises Series A Financing to Adva... (12/23/2025) China Approves First Global CSF-1R Inhib... (12/23/2025) NMPA Announces Revision of Montelukast P... (12/22/2025) Windward Bio Licenses Long-Acting TSLP/I... (12/22/2025) Zelgen Files for Hong Kong IPO, Showcasi... (12/22/2025) AstraZeneca Strengthens KRAS Oncology St... (12/22/2025) Alphamab's IND for PD-L1/VEGFR2 Bispecif... (12/22/2025) Rezubio Raises $20M Series A to Advance ... (12/22/2025) Epigenic Wins FDA IND Clearance for Nove... (12/22/2025) Recent Executive Moves (12/19/2025) China Seeks Public Comments on Draft 101... (12/19/2025) Insilico Targets US$292 Million in Hong ... (12/19/2025)

China's Human Vaccine Market Set for Steady Long-Term E... China's Pharmaceutical Market Enters a New Consumer-Dri... China's Aging Population to Drive Trillion-Dollar Healt... China's Innovative Drug Market Shows Diverging Trends B... Innovent's Weight-Loss Drug Challenges Western Giants i...

PepBio Raises Series A Financing to Advance AI-Driven P... T-MAXIMUM Secures FDA Approval to Advance Off-the-Shelf... Ipsen Expands Oncology Pipeline with Global Licensing o... Grand Secures China Rights to World's First Adrenaline... Aurobindo Pharma to Increase Stake in Chinese JV Luoxin...

NMPA Announces Revision of Montelukast Product Labels t... China Seeks Public Comments on Draft 101st Batch of Ref... China Opens Consultation on First ICH M13A Low-Risk For... CDE Solicits Comments on Draft Guidelines for Generic ... China Launches Pilot Program for Classified Management ...

NHSA Unveils Three-Year Plan to Accelerate BMI Fund Cle... China Pushes Private Insurance to Cover High-Cost Innov... China Releases Updated NRDL and First Commercial Insura... China's Healthcare Costs Shift to Individuals as Govern... China Expands Grassroots Healthcare Access with More Do...

BeOne and AbbVie Resolve Patent Dispute O... Several Chinese Biotech Firms Added to U.S. Entity List... Chinese Scientist Arrested in Houston Over Alleged Thef... U.S. Closes Bribery Investigation into GE Healthcare's ... SAMR Orders Simcere to Reverse Unnotified Merger Over C...

Abraham Accords Partners Could Help the U.S. Reduce Pha... PhIIC Report Highlights China's API Industry Rebound as... India and China Explore Reverse-Trade Model for Pharmac... Clariant Completes Expansion of Pharma Excipients and S... Sanofi Launches €1B Insulin API Manufacturing Project ...

China Approves First Global CSF-1R Inhibitor Pimicotini... Qilu Launches Phase 1 Trial of FIC CD3/CD20/CD79b Tripl... CSPC Announces China Approval for Daratumumab Injection Epigenic Wins FDA IND Clearance for Novel Epigenetic Th... Alphamab's IND for PD-L1/VEGFR2 Bispecific ADC JSKN027 ...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Executive Moves China Moves to Prosecute Former Traditional Medicine Re... Recent Executive Moves Former CFDA Boss Bi Jingquan Expelled From Party, Faces... Recent Executive Moves

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...